Market Overview:
The global dry eye drugs and devices treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of dry eye syndrome, rising awareness about available treatments, and growing demand for novel therapies. By type, the antibiotic drops segment is expected to account for the largest share of the global dry eye drugs and devices treatment market in 2018. By application, hospital pharmacies are expected to account for the largest share of this market in 2018. Geographically, North America is expected to dominate the global dry eye drugs and devices treatment market in 2018.
Product Definition:
Dry eye drugs and devices treatment is the use of medications or devices to treat dry eye. Dry eye is a condition in which there is not enough tears to lubricate the eyes, resulting in discomfort, blurred vision, and increased risk of infection. The main goal of dry eye drug and device treatment is to increase tear production and keep the eyes healthy.
Antibiotic Drops:
Antibiotic drops are used for the treatment of bacterial keratitis. Bacterial keratitis is a rare disease wherein the eye surface is infected by bacteria. The most common bacteria found in this condition includes Streptococcus, Staphylococcus, and Pseudomonas aeruginosa.
Hormone Drops:
Hormone Drops is a new drug developed by Novartis AG for the treatment of dry eye disease. It is currently under phase III clinical trial and expected to be commercialized in 2019. The main objective of this study was to evaluate the safety and efficacy of hormone therapy as compared to cyclic corticosteroids for treating dry eye disease in women above 40 years old, who have been treated with non-surgical artificial tears for more than 6 months without success.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. The hospital pharmacy segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of dry eye disease coupled with rising awareness about treatment among patients at hospitals and healthcare centers.
The increasing number of retail outlets for pharmaceutical products has been driving demand for dry eye drugs and devices over the past few years. A large patient base that prefers to purchase medicines from local stores rather than going online or offline shops is also responsible for driving demand from this segment. In addition, growing preference among patients to have easy access to their medicine cabinets without having to travel all the way up stairs at a shopping mall or supermarket is also expected drive growth from this end-use segment over the forecast period.
The other application category includes clinics/ophthalmic practices.
Regional Analysis:
North America dominated the global dry eye drugs and devices treatment market in 2017. The presence of a large patient pool, sophisticated healthcare infrastructure, high awareness levels coupled with relatively higher disposable income are some of the factors responsible for its large share. Moreover, increasing R&D activities by various companies to develop novel therapeutics and improve existing therapies is expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population prone to dry eye disease as well as increasing disposable income resulting in increased demand for advanced therapeutics among patients suffering from this condition.
Key players operating in Asia Pacific include Alcon (Shanghai) Pharmaceutical Corp., Maybridge Global (Shenzhen) Biotechnology Co., Ltd.
Growth Factors:
- Increasing prevalence of dry eye syndrome: The global prevalence of dry eye syndrome is expected to increase significantly in the next few years, owing to the increasing aging population and rising awareness about the condition. This will create significant demand for dry eye drugs and devices treatment products, thereby driving market growth.
- Growing demand for minimally invasive treatments: There is a growing demand for minimally invasive treatments for dry eye syndrome, as they are less painful and cause fewer side effects than traditional treatments. This is expected to drive market growth in the coming years.
- Technological advancements: The development of novel technologies such as gene therapy and stem cell therapy has led to significant advancements in the field of dry eye drugs and devices treatment, offering new hope to patients suffering from this condition. This is likely to fuel market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dry Eye Drugs and Devices Treatment Market Research Report
By Type
Antibiotic Drops, Hormone Drops, Artificial Tears, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Novartis, Merck, Johnson & Johnson, EyeGate Pharmaceuticals, Allergan, Takeda, Jianfeng Group, Bausch Health, Santen Pharmaceutical, Senju Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Dry Eye Drugs and Devices Treatment Market Report Segments:
The global Dry Eye Drugs and Devices Treatment market is segmented on the basis of:
Types
Antibiotic Drops, Hormone Drops, Artificial Tears, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Merck
- Johnson & Johnson
- EyeGate Pharmaceuticals
- Allergan
- Takeda
- Jianfeng Group
- Bausch Health
- Santen Pharmaceutical
- Senju Pharmaceutical
Highlights of The Dry Eye Drugs and Devices Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotic Drops
- Hormone Drops
- Artificial Tears
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dry Eye Drugs and Devices Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dry eye drugs and devices are treatments that help to improve the symptoms of dry eye. These treatments can include artificial tears, ointments, and supplements.
Some of the key players operating in the dry eye drugs and devices treatment market are Novartis, Merck, Johnson & Johnson, EyeGate Pharmaceuticals, Allergan, Takeda, Jianfeng Group, Bausch Health, Santen Pharmaceutical, Senju Pharmaceutical.
The dry eye drugs and devices treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dry Eye Drugs and Devices Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dry Eye Drugs and Devices Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dry Eye Drugs and Devices Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dry Eye Drugs and Devices Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dry Eye Drugs and Devices Treatment Market Size & Forecast, 2020-2028
4.5.1 Dry Eye Drugs and Devices Treatment Market Size and Y-o-Y Growth
4.5.2 Dry Eye Drugs and Devices Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotic Drops
5.2.2 Hormone Drops
5.2.3 Artificial Tears
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dry Eye Drugs and Devices Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dry Eye Drugs and Devices Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotic Drops
9.6.2 Hormone Drops
9.6.3 Artificial Tears
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotic Drops
10.6.2 Hormone Drops
10.6.3 Artificial Tears
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotic Drops
11.6.2 Hormone Drops
11.6.3 Artificial Tears
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotic Drops
12.6.2 Hormone Drops
12.6.3 Artificial Tears
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotic Drops
13.6.2 Hormone Drops
13.6.3 Artificial Tears
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dry Eye Drugs and Devices Treatment Market: Competitive Dashboard
14.2 Global Dry Eye Drugs and Devices Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Merck
14.3.3 Johnson & Johnson
14.3.4 EyeGate Pharmaceuticals
14.3.5 Allergan
14.3.6 Takeda
14.3.7 Jianfeng Group
14.3.8 Bausch Health
14.3.9 Santen Pharmaceutical
14.3.10 Senju Pharmaceutical
